Penault-Llorca F - Search Results

1

[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

Penault-Llorca F, Vincent-Salomon A, Bellocq JP, Matthieu MC, Grogan GM, Treilleux I, Ettore F, Laberge-Le Couteulx S, Sigal B, Couturier J, Lacroix-Triki M, Antoine M, Balaton A, Baranzelli MC, Becette V, Blanc-Fournier C, Bibeau F, Brabencova E, Croce S, Fridman V, Génin P, Ghnassia JP, Jacquemier J, Poulet B, Roger P, Sagan C, Tas P, Trassard M, Verriele V, Arnould L; GEFPICS. Penault-Llorca F, et al. Ann Pathol. 2010 Oct;30(5):357-73. doi: 10.1016/j.annpat.2010.07.001. Epub 2010 Oct 16. Ann Pathol. 2010. PMID: 21055523 French.

2

The Heregulin gene can be included in the 8p12 amplification unit in human breast cancer.

Adélaïde J, Penault-Llorca F, Dib A, Yarden Y, Jacquemier J, Birnbaum D. Adélaïde J, et al. Genes Chromosomes Cancer. 1994 Sep;11(1):66-9. doi: 10.1002/gcc.2870110111. Genes Chromosomes Cancer. 1994. PMID: 7529049

3

Expression of the FGFR1 gene in human breast-carcinoma cells.

Jacquemier J, Adelaide J, Parc P, Penault-Llorca F, Planche J, deLapeyriere O, Birnbaum D. Jacquemier J, et al. Int J Cancer. 1994 Nov 1;59(3):373-8. doi: 10.1002/ijc.2910590314. Int J Cancer. 1994. PMID: 7927944

4

Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation.

Penault-Llorca F, Adelaïde J, Houvenaeghel G, Hassoun J, Birnbaum D, Jacquemier J. Penault-Llorca F, et al. J Pathol. 1994 May;173(1):65-75. doi: 10.1002/path.1711730111. J Pathol. 1994. PMID: 7931839

5

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.

Jacquemier JD, Penault-Llorca FM, Bertucci F, Sun ZZ, Houvenaeghel GF, Geneix JA, Puig BD, Bardou VJ, Hassoun JA, Birnbaum D, Viens PJ. Jacquemier JD, et al. J Pathol. 1998 Feb;184(2):130-5. doi: 10.1002/(SICI)1096-9896(199802)184:2<130::AID-PATH19>3.0.CO;2-W. J Pathol. 1998. PMID: 9602702

6

FGF7 protein expression in human breast carcinomas.

Jacquemier J, Sun ZZ, Penault-Llorca F, Geneix J, Devilard E, Adélaïde J, Birnbaum D. Jacquemier J, et al. J Pathol. 1998 Nov;186(3):269-74. doi: 10.1002/(SICI)1096-9896(1998110)186:3<269::AID-PATH187>3.0.CO;2-G. J Pathol. 1998. PMID: 10211115

7

[Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?].

Penault-Llorca F, Jacquemier J. Penault-Llorca F, et al. Ann Pathol. 1999 Apr;19(2):103-15. Ann Pathol. 1999. PMID: 10349474 Review. French. No abstract available.

8

[Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS)].

Penault-Llorca F, Jacquemier J, Le Doussal V, Voigt JJ. Penault-Llorca F, et al. Ann Pathol. 1999 Sep;19(4):280-2. Ann Pathol. 1999. PMID: 10544761 French. No abstract available.

9

[Monoclonal antibodies in oncology: applications in diagnosis, prognosis and prediction of response to therapy on tissue specimens].

Penault-Llorca FM, Balaton AJ. Penault-Llorca FM, et al. Bull Cancer. 2000 Nov;87(11):794-803. Bull Cancer. 2000. PMID: 11125288 Free article. Review. French.

10

[Immunochemistry evaluation of HER2 status in infiltration breast cancer: technical protocol and interpretation guidelines].

Penault-Llorca F, Balaton A, Sabourin JC, Le Doussal V; Groupe d'évaluation des facteurs pronostiques par immunohistochimie dans les cancers du sein (GEFPICS). Penault-Llorca F, et al. Ann Pathol. 2002 Apr;22(2):150-7. Ann Pathol. 2002. PMID: 12124503 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters